Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Undecaprenyl-diphosphatase (UppP/BacA) is an essential bacterial integral membrane enzyme that catalyzes the dephosphorylation of undecaprenyl pyrophosphate (UPP) to undecaprenyl phosphate (UP). UP is a vital 55-carbon lipid carrier (bactoprenol) required to shuttle peptidoglycan, O-antigen, and teichoic acid precursors across the cytoplasmic membrane during cell wall biosynthesis. Because the pool of UP is limited, its continuous recycling from UPP (released after precursor polymerisation) by UppP/BacA is critical for maintaining cell wall integrity and preventing bacterial lysis. UppP/BacA accounts for the majority of UPP phosphatase activity in many bacteria, such as Escherichia coli, and its genetic deletion or inhibition leads to altered cell morphology, reduced mechanical stiffness, and increased sensitivity to environmental and host-induced stresses.
The enzyme is a prime target for antibacterial drug development; the classic antibiotic bacitracin acts by sequestering the UPP substrate, thereby preventing its dephosphorylation by UppP/BacA. Additionally, the clinical-stage antitubercular drug SQ109 and various experimental small molecules (such as sulfamoylthiophenes and biphenylthiazoles) have been shown to directly inhibit UppP/BacA or its orthologs, collapsing cell wall synthesis and offering a promising therapeutic strategy against multi-drug resistant pathogens.
Direct inhibition of the undecaprenyl-diphosphatase enzyme, blocking the dephosphorylation of undecaprenyl pyrophosphate (UPP) to undecaprenyl phosphate (UP), which depletes the essential lipid carrier pool and halts bacterial cell wall synthesis. Alternatively, substrate sequestration (e.g., by bacitracin) prevents the enzyme from accessing UPP.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undecaprenyl-diphosphatase (UppP).